Sara M. Elgendy

Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines

Kholoud Y. I. Abushawish, Sameh S. M. Soliman, Alexander D. Giddey et al. · International Journal of Molecular Sciences · 2022 · 18 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization

Chih-Jia Chao, Zhang Endong, Edidiong Udofa et al. · Nature Communications · 2025 · 14 citations · Full text

Life Sciences, Immunology, Oncology +17

Tangeretin as an adjuvant and chemotherapeutic sensitizer against various types of cancers: a comparative overview

Dima W. Alhamad, Sara M. Elgendy, Taleb H. Al‐Tel et al. · Journal of Pharmacy and Pharmacology · 2021 · 12 citations

Medicine, Oncology, Pharmacology +14

Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors

Reinad R. Abu Rabah, Anusha Sebastian, Vunnam Srinivasulu et al. · Bioorganic & Medicinal Chemistry · 2022 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

The inhibition of autophagy by spautin boosts the anticancer activity of fingolimod in multidrug-resistant hepatocellular carcinoma

Dima W. Alhamad, Sara M. Elgendy, Fatema Hersi et al. · Life Sciences · 2022 · 10 citations

Medicine, Oncology, Pharmacology +14